PlenOptika's QuickSee, a handheld autorefractor designed to reduce global uncorrected refractive error, can dramatically increase access to eyeglasses, according to researchers. The paper, published
The Centre for Ocular Research and Education (CORE) has released an update exploring whether increasing use of screens affects ocular comfort and can ultimately lead to dry eye
Eight New Zealand optometrists have won OPSM’s Luxottica Eyecare Development Award (LEDA), a scholarship valued at $5,189 each to advance their skills.
Serengeti’s Geary has been named global tech magazine T3's best driving sunglasses for its “stylish unisex design and superior clarity in bright light conditions”.
The latest acetate line from JF Rey offers striking artistic flair and refreshing colours contrasts, beautifully crafted in flattering oversized shapes. Model JF1510’s
More often associated with poisoning and death in poorly ventilated homes with old gas ranges, a new study suggests that carbon monoxide (CO) in very small doses may protect against diabetic retinopathy (DR).
New contact lens (CL) technology designed to help diagnose and monitor medical conditions may soon be ready for clinical trials, revealed Purdue University researchers.
American-Swiss surgical product company Alcon announced it will acquire Ivantis, makers of the minimally invasive glaucoma surgery (MIGS) device the Hydrus Microstent, for an initial US$475m.
Medix 21 Surgical has introduced SIFI’s Eyestil Synfo moisturising eye drops for dry eye disease (DED) in New Zealand.
RANZCO’s Women in Ophthalmology has issued a new podcast series, 10 minutes of Science, featuring women ophthalmologists discussing an article of their choosing in their respective specialist
Digital therapeutics company Luminopia has received the US Food and Drug Administration’s (FDA) De Novo premarket approval for Luminopia One, which uses TV shows to improve vision in children with
A GP screening diabetic patients using oDocs Eye Care’s Nun ophthalmoscope diagnosed diabetic retinopathy (DR) with 90% sensitivity and diabetic macular oedema (DMO) with 20% sensitivity. Led by Dr